APA
Ravdin P. M., Green S., Dorr T. M., McGuire W. L., Fabian C., Pugh R. P., Carter R. D., Rivkin S. E., Borst J. R. & Belt R. J. (19920825). Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Ravdin P M, Green S, Dorr T M, McGuire W L, Fabian C, Pugh R P, Carter R D, Rivkin S E, Borst J R and Belt R J. 19920825. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Ravdin P. M., Green S., Dorr T. M., McGuire W. L., Fabian C., Pugh R. P., Carter R. D., Rivkin S. E., Borst J. R. and Belt R. J. (19920825). Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Ravdin P M, Green S, Dorr T M, McGuire W L, Fabian C, Pugh R P, Carter R D, Rivkin S E, Borst J R and Belt R J. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19920825.